Roche largely focuses on cancer and autoimmune-focused diagnostics and treatments. This acquisition will expand Roche’s offering to include InterMune’s respiratory offerings.
More articles on acquisitions:
Cleveland Clinic finalizes Akron General minority ownership deal
Duke LifePoint, Conemaugh Health reach definitive acquisition agreement
Allergan, Salix in potential merger talks
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.